Dáil Éireann Debate, Tuesday - 13 July 2021
108. Deputy Alan Kelly asked the Minister for Health when a catch-up programme will commence for the HPV vaccine for secondary school students due to missed vaccines during the Covid-19 pandemic; and if he will make a statement on the matter. [37592/21]
Amharc ar fhreagraThe ages at which vaccines are recommended in the immunisation schedule are chosen by the National Immunisation Advisory Committee (NIAC) in order to give each child the best possible protection against vaccine preventable diseases.
As the HPV vaccine is preventative it is intended to be administered, if possible, before a person becomes sexually active, that is, before a person is first exposed to HPV infection.
Therefore, the gender-neutral HPV vaccination programme targets all girls and boys in their first year of secondary school to provide maximum coverage.
My Department will continue to be guided by the NIAC's recommendations on any emerging evidence on this issue in the future.
It is important to note that the schools-based immunisation programme for the 2019/2020 academic year has been completed and the uptake rates for the HPV vaccine in that academic year are 82% for the first dose of the vaccine and 77% for the second dose.
This is the highest uptake for the HPV vaccination programme since 2015/2016 and is particularly encouraging because it was the first year that boys were included in the programme and it shows that the provision of vaccine in community clinics did not adversely affect the uptake.
The programme for the academic year 2020/2021 was paused during the first few months of 2021 due to school closures and redeployment of staff to the COVID-19 immunisation programme.
The inputting of uptake information for the schools-based programme has also been delayed due to redeployment of administrative staff. However, Community Healthcare Organisations have reported that the vast majority of second level schools had their first dose of HPV vaccine delivered between October and December 2020.
The uptake rate for the first dose of the HPV vaccine, in the 2020/2021 academic year, is 67% as of the 12th May 2021, and this figure is expected to increase because data input on vaccine uptake is ongoing.
The HSE expects the HPV vaccination programme for 2020/21 to be substantially complete before the start of the 2021/22 academic year.
